aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Oil falls as diplomacy hopes outweigh Middle East escalation fears
- SK Hynix shares surge after Q3 profit beats expectations
Tweet
Share
E-mailGet Alerts ATYR Hot Sheet
Join SI Premium – FREE
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EMCOR Group (EME) Tops Q3 EPS by 123c; raises guidance
- Allegro MicroSystems, Inc. (ALGM) Tops Q2 EPS by 2c
- Belden (BDC) Reports In-Line Q3 EPS ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
